The data establish the first clinical proof-of-mechanism for RNA activation (RNAa) in a human monogenic disease, ...
Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that ...
Lonza, the world's leading contract development and manufacturing organization (CDMO), and Asimov, the company building an AI ...
Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...
Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...
Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research ...
Hengrui Pharma announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready ...
Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...
FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in ...
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data ...
Continued investment in Vetter’s broader operational infrastructure accompanies the expansion of its manufacturing capacity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results